GRAIL, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GRAL Nasdaq 2836 grail.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for GRAIL, Inc.

Grail Stock Has Skyrocketed 171% in 6 Months. Where Will It Be in 5 Years? - Oct 4th, 2026 8:13 am
Why GRAIL (GRAL) Is Up 12.9% After Positive FDA Panel Verdict On Galleri Trial Results - Oct 3rd, 2026 12:07 am
3 Reasons to Buy Grail (GRAL) Hand Over Fist in October - Sep 30th, 2026 11:35 am
Grail Stock Has Soared 180% in 6 Months. Here's Why the Stock Has More Room to Run. - Sep 30th, 2026 6:20 am
Why Grail Stock Skyrocketed Nearly 70% In A Week. What To Watch Next. - Sep 30th, 2026 6:00 am
Here's Why Grail Stock Surged 55% This Week - Sep 25th, 2026 3:25 am
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better - Sep 24th, 2026 9:23 pm
GRAIL (GRAL) Wins FDA Panel Backing, Is It Now Overvalued? - Sep 24th, 2026 2:17 pm
Grail Surges After FDA Advisors Back Its Cancer-Finding Blood Test - Sep 24th, 2026 2:13 pm
Dow Jones Futures Fall As Treasury Yields, Oil Prices Keep Rising. Meta, Everpure, Grail Are Early Movers. - Sep 24th, 2026 6:04 am
The Holy Grail In Cancer? FDA Panel Backs Blood Tests - Sep 23rd, 2026 4:44 pm
FDA Advisory Committee Votes In Favor of Approval of GRAIL's Galleri® Multi-Cancer Early Detection Test - Sep 23rd, 2026 4:17 pm
GRAIL Stock Jumped 34% Yesterday. The FDA Just Told Its Investors Why. - Sep 22nd, 2026 12:07 am
GRAL Stock Clocks Best Day In Over 1.5 Years — FDA Papers Lift Galleri Approval Hopes - Sep 21st, 2026 2:50 pm
Grail Catapults 30%-Plus As FDA Mulls Cancer-Detecting Blood Test - Sep 21st, 2026 2:14 pm
FDA Decision Watch: MRK, MIRM, INCY, GRAL Face Key Regulatory Catalysts This Week - Sep 21st, 2026 5:06 am
Grail CFO Aaron Freidin Sells 7,900 Shares for $672,000 - Sep 8th, 2026 9:15 pm
Grail Stock Jumps in August as FDA Schedules a Key Meeting for its Galleri Cancer Test - Sep 4th, 2026 6:10 am
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Sep 3rd, 2026 2:02 pm
GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference - Aug 31st, 2026 2:01 pm